C40B40/08

Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions

Libraries of immunoglobulins which each have one or more amino acid modifications in at least one structural loop region of such immunoglobulins, where the modified loop region specifically binds to an epitope of an antigen to which an unmodified immunoglobulin does not significantly bind.

Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions

Libraries of immunoglobulins which each have one or more amino acid modifications in at least one structural loop region of such immunoglobulins, where the modified loop region specifically binds to an epitope of an antigen to which an unmodified immunoglobulin does not significantly bind.

MODIFIED POLYPEPTIDE OF MESO-DIAMINOPIMELATE DEHYDROGENASE AND METHOD FOR PRODUCING L-THREONINE USING THE SAME
20220356479 · 2022-11-10 ·

The present disclosure relates to a modified polypeptide, in which the activity of meso-diaminopimelate is weakened, and a method for producing L-threonine using the same.

MODIFIED POLYPEPTIDE OF MESO-DIAMINOPIMELATE DEHYDROGENASE AND METHOD FOR PRODUCING L-THREONINE USING THE SAME
20220356479 · 2022-11-10 ·

The present disclosure relates to a modified polypeptide, in which the activity of meso-diaminopimelate is weakened, and a method for producing L-threonine using the same.

NUCLEIC ACID COMPLEXES FOR SCREENING BARCODED COMPOUNDS

The invention provides compositions comprising nucleic acid complexes for use in screening compounds based on their ability to modulate binding interactions, wherein the compounds are barcoded.

NUCLEIC ACID COMPLEXES FOR SCREENING BARCODED COMPOUNDS

The invention provides compositions comprising nucleic acid complexes for use in screening compounds based on their ability to modulate binding interactions, wherein the compounds are barcoded.

VARIANT NUCLEIC ACID LIBRARIES FOR ION CHANNELS
20220356468 · 2022-11-10 ·

Provided herein are methods and compositions relating to ion channel libraries having nucleic acids encoding for a scaffold comprising a natural peptide toxin. Ion channel libraries described herein encode for immunoglobulins such as antibodies.

Sample multiplexing for single-cell RNA sequencing

Disclosed herein include systems, methods, compositions, and kits for multiplexing single-cell RNA-sequencing (scRNA-seq) samples. In some embodiments, the methods comprise chemically tagging cells with identifying sample tags (e.g., barcoded DNA oligonucleotides).

Sample multiplexing for single-cell RNA sequencing

Disclosed herein include systems, methods, compositions, and kits for multiplexing single-cell RNA-sequencing (scRNA-seq) samples. In some embodiments, the methods comprise chemically tagging cells with identifying sample tags (e.g., barcoded DNA oligonucleotides).

Variant nucleic acid libraries for GLP1 receptor

Provided herein are methods and compositions relating to glucagon-like peptide-1 receptor (GLP1R) libraries having nucleic acids encoding for a scaffold comprising a GLP1R binding domain. Libraries described herein include variegated libraries comprising nucleic acids each encoding for a predetermined variant of at least one predetermined reference nucleic acid sequence. Further described herein are protein libraries generated when the nucleic acid libraries are translated. Further described herein are cell libraries expressing variegated nucleic acid libraries described herein.